Detection of Minimal Residual Disease Post-prostatectomy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Detection of Minimal Residual Disease Post-prostatectomy — Stella

Recruiting

Back to Prostate Cancer trials

Trial locations(1 site)

Netherlands

Prosper Prostate Cancer Clinics, Nijmegen

Key details

Sponsor

Radboud University Medical Center

Collaborators

Catharina Ziekenhuis Eindhoven, Canisius-Wilhelmina Hospital

Enrollment target

~50 participants

Started

September 2025

Primary completion

July 2027

Age range

18 Years and older

Sex

Male only

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov